Ampio Pharmaceuticals Inc - Company & Market Research Reports

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

From
From
From
Osteoarthritis Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 224 Pages
From
Osteoarthritis Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 202 Pages
From
From
From
Neuroblastoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 543 Pages
From
Neuroblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • 506 Pages
From
From
From
Neuroblastoma - Pipeline Insight, 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
From
Loading Indicator
adroll